This bibliography shows the most interesting papers selected from pmc PubMedCentral which were newly included in covid019I
It is available online and for download at http://www.kidney.de/write/PMCmedVIP_covid019I.html
Skewed: Nephrology, Rheumatology, Immunology, Cell Biology, Research Methods. on-topic and educational Clinical Medicine.
The full table of all monthly collections is: at house-of-papers.com
PMC searches were done at moremed.org





{{tp|p=32918894|t=2020. Stability of severe acute respiratory syndrome coronavirus 2 RNA in placenta and fetal cells.|pdf=|usr=}}
{{tp|p=32866527|t=2020. Confirmatory evidence of the visualization of severe acute respiratory syndrome coronavirus 2 invading the human placenta using electron microscopy.|pdf=|usr=}}
{{tp|p=32858014|t=2020. Comparative nanostructure consideration on novel coronavirus and possibility of transplacental transmission.|pdf=|usr=}}
{{tp|p=32853537|t=2020. Expression of severe acute respiratory syndrome coronavirus 2 cell entry genes, angiotensin-converting enzyme 2 and transmembrane protease serine 2, in the placenta across gestation and at the maternal-fetal interface in pregnancies complicated by preterm birth or preeclampsia.|pdf=|usr=}}
{{tp|p=33020692|t=2020. In-host Mathematical Modelling of COVID-19 in Humans.|pdf=|usr=}}
{{tp|p=32904415|t=2020. A data-driven understanding of COVID-19 dynamics using sequential genetic algorithm based probabilistic cellular automata.|pdf=|usr=}}
{{tp|p=32901204|t=2020. Analyzing COVID-19 virus based on enhanced fragmented biological Local Aligner using improved Ions Motion Optimization algorithm.|pdf=|usr=}}
{{tp|p=32943188|t=2020. RNA-dependent RNA polymerase: Structure, mechanism, and drug discovery for COVID-19.|pdf=|usr=}}
{{tp|p=32981683|t=2020. Machine learning methods accurately predict host specificity of coronaviruses based on spike sequences alone.|pdf=|usr=}}
{{tp|p=32931703|t=2020. Sequence Characterization and Molecular Modeling of Clinically Relevant Variants of the SARS-CoV-2 Main Protease.|pdf=|usr=}}
{{tp|p=32976572|t=2020. COVID-19 Knowledge Graph: a computable, multi-modal, cause-and-effect knowledge model of COVID-19 pathophysiology.|pdf=|usr=}}
{{tp|p=32994678|t=2020. Comparative molecular docking analysis of the SARS CoV-2 Spike glycoprotein with the human ACE-2 receptors and thrombin.|pdf=|usr=}}
{{tp|p=32994673|t=2020. CoViD-19 Susceptibility.|pdf=|usr=}}
{{tp|p=32923488|t=2020. Adaptive Evolution of Feline Coronavirus Genes Based on Selection Analysis.|pdf=|usr=}}
{{tp|p=32933047|t=2020. Why COVID-19 Transmission Is More Efficient and Aggressive Than Viral Transmission in Previous Coronavirus Epidemics?|pdf=|usr=}}
{{tp|p=32895643|t=2020. Genomic characterization of SARS-CoV-2 identified in a reemerging COVID-19 outbreak in Beijing's Xinfadi market in 2020.|pdf=|usr=}}
{{tp|p=33008363|t=2020. Real-time audio and visual display of the Coronavirus genome.|pdf=|usr=}}
{{tp|p=32993540|t=2020. A young adult with COVID-19 and multisystem inflammatory syndrome in children (MIS-C)-like illness: a case report.|pdf=|usr=}}
{{tp|p=32892755|t=2020. Obesity, COVID-19 and innate immunometabolism.|pdf=|usr=}}
{{tp|p=32975865|t=2020. Expression of ACE2 in airways: Implication for COVID-19 risk and disease management in patients with chronic inflammatory respiratory diseases.|pdf=|usr=}}
{{tp|p=32978971|t=2020. Innate immunity during SARS-CoV-2: evasion strategies and activation trigger hypoxia and vascular damage.|pdf=|usr=}}
{{tp|p=32864374|t=2020. Coronavirus epitope prediction from highly conserved region of spike protein.|pdf=|usr=}}
{{tp|p=32920210|t=2020. On the genetics and immunopathogenesis of COVID-19.|pdf=|usr=}}
{{tp|p=32866645|t=2020. Interferon gamma, TGF-beta1 and RANTES expression in upper airway samples from SARS-CoV-2 infected patients.|pdf=|usr=}}
{{tp|p=32898238|t=2020. Sustained responses of neutralizing antibodies against MERS-CoV in recovered patients and their therapeutic applicability.|pdf=|usr=}}
{{tp|p=32997739|t=2020. Severe COVID-19 is associated with elevated serum IgA and antiphospholipid IgA-antibodies.|pdf=|usr=}}
{{tp|p=32130405|t=2020. 2019 Novel Coronavirus Is Undergoing Active Recombination.|pdf=|usr=}}
{{tp|p=32797228|t=2020. Potential antigenic cross-reactivity between SARS-CoV-2 and Dengue viruses.|pdf=|usr=}}
{{tp|p=32898715|t=2020. The kinetics of viral load and antibodiesto SARS-CoV-2.|pdf=|usr=}}
{{tp|p=33005417|t=2020. Antibody seroconversion in asymptomatic and symptomatic patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).|pdf=|usr=}}
{{tp|p=32989903|t=2020. COVID-19 and immunological dysregulation: can autoantibodies be useful?|pdf=|usr=}}
{{tp|p=32983400|t=2020. Computational biophysical characterization of the SARS-CoV-2 spike protein binding with the ACE2 receptor and implications for infectivity.|pdf=|usr=}}
{{tp|p=32983399|t=2020. An immersive journey to the molecular structure of SARS-CoV-2: Virtual reality in COVID-19.|pdf=|usr=}}
{{tp|p=32894160|t=2020. Assessment of pulmonary surfactant in COVID-19 patients.|pdf=|usr=}}
{{tp|p=32988728|t=2020. Is Toll-like receptor 4 involved in the severity of COVID-19 pathology in patients with cardiometabolic comorbidities?|pdf=|usr=}}
{{tp|p=33017040|t=2020. Durability of neutralizing antibodies and T-cell response post SARS-CoV-2 infection.|pdf=|usr=}}
{{tp|p=32979342|t=2020. Compartmental immunophenotyping in COVID-19 ARDS: a case series.|pdf=|usr=}}
{{tp|p=32895779|t=2020. Coronavirus: a shift in focus away from IFN response and towards other inflammatory targets.|pdf=|usr=}}
{{tp|p=32944935|t=2020. Single-cell RNA sequencing analysis of SARS-CoV-2 entry receptors in human organoids.|pdf=|usr=}}
{{tp|p=32897993|t=2020. Challenges in Diagnosing Multisystem Inflammatory Syndrome Related to SARS-CoV-2 in a Child With Severe Neurocognitive Impairment and Social Isolation.|pdf=|usr=}}
{{tp|p=32814701|t=2020. The Urgency of Conducting Serological Studies for COVID-19.|pdf=|usr=}}
{{tp|p=32788194|t=2020. Optimized Pseudotyping Conditions for the SARS-COV-2 Spike Glycoprotein.|pdf=|usr=}}
{{tp|p=33024281|t=2020. Cross-reactive memory T cells and herd immunity to SARS-CoV-2.|pdf=|usr=}}
{{tp|p=32943538|t=2020. Systemic complement activation is associated with respiratory failure in COVID-19 hospitalized patients.|pdf=|usr=}}
{{tp|p=32989130|t=2020. Superantigenic character of an insert unique to SARS-CoV-2 spike supported by skewed TCR repertoire in patients with hyperinflammation.|pdf=|usr=}}
{{tp|p=32963094|t=2020. Transmission dynamics reveal the impracticality of COVID-19 herd immunity strategies.|pdf=|usr=}}
{{tp|p=32964627|t=2020. Immune response following infection with SARS-CoV-2 and other coronaviruses: A rapid review.|pdf=|usr=}}
{{tp|p=32946131|t=2020. Investigation of immune cells on elimination of pulmonary-Infected COVID-19 and important role of innate immunity, phagocytes.|pdf=|usr=}}
{{tp|p=32928234|t=2020. Characterization of codon usage pattern in SARS-CoV-2.|pdf=|usr=}}
{{tp|p=33011520|t=2020. Molecular and serological characterization of SARS-CoV-2 infection among COVID-19 patients.|pdf=|usr=}}
{{tp|p=32979477|t=2020. Signal hotspot mutations in SARS-CoV-2 genomes evolve as the virus spreads and actively replicates in different parts of the world.|pdf=|usr=}}
{{tp|p=32918944|t=2020. SARS-CoV-2 host tropism: An in silico analysis of the main cellular factors.|pdf=|usr=}}
{{tp|p=33003587|t=2020. Interaction of Human ACE2 to Membrane-Bound SARS-CoV-1 and SARS-CoV-2 S Glycoproteins.|pdf=|usr=}}
{{tp|p=32992592|t=2020. Host Immune Response Driving SARS-CoV-2 Evolution.|pdf=|usr=}}
{{tp|p=32971895|t=2020. Identification of a Membrane Binding Peptide in the Envelope Protein of MHV Coronavirus.|pdf=|usr=}}
{{tp|p=32967229|t=2020. Immune Checkpoints in Viral Infections.|pdf=|usr=}}
{{tp|p=32961897|t=2020. Induction of the Antiviral Immune Response and Its Circumvention by Coronaviruses.|pdf=|usr=}}
{{tp|p=32937868|t=2020. Spatio-Temporal Mutational Profile Appearances of Swedish SARS-CoV-2 during the Early Pandemic.|pdf=|usr=}}
{{tp|p=32929876|t=2020. The Longitudinal Immune Response to Coronavirus Disease 2019: Chasing the Cytokine Storm.|pdf=|usr=}}
{{tp|p=32964796|t=2020. Coronavirus interactions with the cellular autophagy machinery.|pdf=|usr=}}
{{tp|p=32975439|t=2020. Cardiac Findings in Pediatric Patients With Multisystem Inflammatory Syndrome in Children Associated With COVID-19.|pdf=|usr=}}
{{tp|p=32912123|t=2020. Emerging Novel Coronavirus is a Global Threat: Insight in the Biology of COVID-19 and its Hijacking Process of Hosts' Cell.|pdf=|usr=}}
{{tp|p=33019935|t=2020. COVID-19: a Great Mime or a Trigger Event of Autoimmune Manifestations?|pdf=|usr=}}
{{tp|p=33016156|t=2020. Hypothesis: The electrical properties of coronavirus.|pdf=|usr=}}
{{tp|p=32914439|t=2020. Structures of the SARS-CoV-2 nucleocapsid and their perspectives for drug design.|pdf=|usr=}}
{{tp|p=32972235|t=2020. Secondary hemophagocytic lymphohistiocytosis versus cytokine release syndrome in severe COVID-19 patients.|pdf=|usr=}}
{{tp|p=32990479|t=2020. Diagnosis of SARS-CoV-2 infection in the setting of the cytokine release syndrome.|pdf=|usr=}}
{{tp|p=32986664|t=2020. COVID-19: Significance of antibodies.|pdf=|usr=}}
{{tp|p=32981399|t=2020. COVID-19 Infection: Concise Review Based on the Immunological Perspective.|pdf=|usr=}}
{{tp|p=33010854|t=2020. COVID-19-Related Multisystem Inflammatory Syndrome in Children Affects Left Ventricular Function and Global Strain Compared with Kawasaki Disease.|pdf=|usr=}}
{{tp|p=33023287|t=2020. COVID-19 and Multisystem Inflammatory Syndrome, or is it Mast Cell Activation Syndrome?|pdf=|usr=}}
{{tp|p=32945158|t=2020. Mast cells activated by SARS-CoV-2 release histamine which increases IL-1 levels causing cytokine storm and inflammatory reaction in COVID-19.|pdf=|usr=}}
{{tp|p=33016027|t=2020. Coronavirus-19 (SARS-CoV-2) induces acute severe lung inflammation via IL-1 causing cytokine storm in COVID-19: a promising inhibitory strategy.|pdf=|usr=}}
{{tp|p=32948117|t=2020. Household pets and SARS-CoV2 transmissibility in the light of the ACE2 intrinsic disorder status.|pdf=|usr=}}
{{tp|p=32901940|t=2020. ACE2: Its potential role and regulation in severe acute respiratory syndrome and COVID-19.|pdf=|usr=}}
{{tp|p=32926425|t=2020. Th17 and Treg cells function in SARS-CoV2 patients compared with healthy controls.|pdf=|usr=}}
{{tp|p=33022076|t=2020. Immunobiology and immunotherapy of COVID-19: A clinically updated overview.|pdf=|usr=}}
{{tp|p=32962383|t=2020. Mathematical modeling and cellular automata simulation of infectious disease dynamics: Applications to the understanding of herd immunity.|pdf=|usr=}}
{{tp|p=32910875|t=2020. Is 'inflammaging' fuelling severe COVID-19 disease?|pdf=|usr=}}
{{tp|p=32817223|t=2020. Cryo-electron Microscopy Structure of the Swine Acute Diarrhea Syndrome Coronavirus Spike Glycoprotein Provides Insights into Evolution of Unique Coronavirus Spike Proteins.|pdf=|usr=}}
{{tp|p=32880615|t=2020. Cytokine Levels in Critically Ill Patients With COVID-19 and Other Conditions.|pdf=|usr=}}
{{tp|p=32840583|t=2020. Difficult to Determine Herd Immunity Threshold for COVID-19.|pdf=|usr=}}
{{tp|p=32808969|t=2020. Neutralizing Antibodies Against SARS-CoV-2-Important Questions, Unclear Answers.|pdf=|usr=}}
{{tp|p=32795406|t=2020. Pseudotumor cerebri syndrome associated with MIS-C: a case report.|pdf=|usr=}}
{{tp|p=32960167|t=2020. Immunite adaptative contre le virus SARS-CoV-2.|pdf=|usr=}}
{{tp|p=32905684|t=2020. Trained Innate Immunity, Epigenetics, and Covid-19.|pdf=|usr=}}
{{tp|p=32966713|t=2020. Loss of Anti-SARS-CoV-2 Antibodies in Mild Covid-19. Reply.|pdf=|usr=}}
{{tp|p=32966712|t=2020. Loss of Anti-SARS-CoV-2 Antibodies in Mild Covid-19.|pdf=|usr=}}
{{tp|p=32966711|t=2020. Loss of Anti-SARS-CoV-2 Antibodies in Mild Covid-19.|pdf=|usr=}}
{{tp|p=32966710|t=2020. Loss of Anti-SARS-CoV-2 Antibodies in Mild Covid-19.|pdf=|usr=}}
{{tp|p=32999467|t=2020. SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognition.|pdf=|usr=}}
{{tp|p=32788748|t=2020. Single-cell landscape of immunological responses in patients with COVID-19.|pdf=|usr=}}
{{tp|p=32855555|t=2020. The dynamic changes in cytokine responses in COVID-19: a snapshot of the current state of knowledge.|pdf=|usr=}}
{{tp|p=32895541|t=2020. T cells in COVID-19 - united in diversity.|pdf=|usr=}}
{{tp|p=32887977|t=2020. Broad and strong memory CD4(+) and CD8(+) T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19.|pdf=|usr=}}
{{tp|p=32929268|t=2020. Seasonal coronavirus protective immunity is short-lasting.|pdf=|usr=}}
{{tp|p=32382153|t=2020. Protecting the population with immune individuals.|pdf=|usr=}}
{{tp|p=32812012|t=2020. Peripheral immunophenotypes in children with multisystem inflammatory syndrome associated with SARS-CoV-2 infection.|pdf=|usr=}}
{{tp|p=32908214|t=2020. Antibody-dependent enhancement and SARS-CoV-2 vaccines and therapies.|pdf=|usr=}}
{{tp|p=32690955|t=2020. Inhibition of the integrated stress response by viral proteins that block p-eIF2-eIF2B association.|pdf=|usr=}}
{{tp|p=32788708|t=2020. The type I interferon response in COVID-19: implications for treatment.|pdf=|usr=}}
{{tp|p=32908316|t=2020. SARS-CoV-2 Nsp1 binds the ribosomal mRNA channel to inhibit translation.|pdf=|usr=}}
{{tp|p=32906143|t=2020. The coding capacity of SARS-CoV-2.|pdf=|usr=}}
{{tp|p=32942285|t=2020. Receptor binding and priming of the spike protein of SARS-CoV-2 for membrane fusion.|pdf=|usr=}}
{{tp|p=32901123|t=2020. The coronavirus is mutating - does it matter?|pdf=|usr=}}
{{tp|p=32895961|t=2020. Neuropathological findings in two patients with fatal COVID-19.|pdf=|usr=}}
{{tp|p=32935873|t=2020. Invited Review: The spectrum of neuropathology in COVID-19.|pdf=|usr=}}
{{tp|p=32981462|t=2020. The COVID-19 Effect on the Immune System and Mitochondrial Dynamics in Diabetes, Obesity, and Dementia.|pdf=|usr=}}
{{tp|p=32925824|t=2020. Bronchopulmonary MDR protein expression may protect against COVID-19 infection.|pdf=|usr=}}
{{tp|p=32932334|t=2020. Multisystem Inflammatory Syndrome Associated With COVID-19 With Neurologic Manifestations in a Child: A Brief Report.|pdf=|usr=}}
{{tp|p=33021596|t=2020. Serum Responses of Children With Kawasaki Disease Against Severe Acute Respiratory Syndrome Coronavirus 2 Proteins.|pdf=|usr=}}
{{tp|p=32994342|t=2020. Coronavirus hemagglutinin-esterase and spike proteins coevolve for functional balance and optimal virion avidity.|pdf=|usr=}}

{{tp|p=32997488|t=2020. Chemosensory Dysfunction in COVID-19: Integration of Genetic and Epidemiological Data Points to D614G Spike Protein Variant as a Contributing Factor.|pdf=|usr=}}
{{tp|p=32946224|t=2020. Structural, Biophysical, and Biochemical Elucidation of the SARS-CoV-2 Nonstructural Protein 3 Macro Domain.|pdf=|usr=}}
{{tp|p=32934769|t=2020. Striking Similarities between CDRs in Some mAbs That Neutralize COVID-19.|pdf=|usr=}}
{{tp|p=33006576|t=2020. Room-temperature neutron and X-ray data collection of 3CL M(pro) from SARS-CoV-2.|pdf=|usr=}}
{{tp|p=33020343|t=2020. The Management of Cytokine Storm in COVID-19.|pdf=|usr=}}
{{tp|p=32895623|t=2020. Crystal structure of SARS-CoV-2 papain-like protease.|pdf=|usr=}}
{{tp|p=32962761|t=2020. Severe COVID-19: what have we learned with the immunopathogenesis?|pdf=|usr=}}
{{tp|p=32991323|t=2020. SARS-CoV-2, immunosenescence and inflammaging: partners in the COVID-19 crime.|pdf=|usr=}}
{{tp|p=33006233|t=2020. COVID-19 is an emergent disease of aging.|pdf=|usr=}}
{{tp|p=32955770|t=2020. Cellular senescence as a potential mediator of COVID-19 severity in the elderly.|pdf=|usr=}}
{{tp|p=32956495|t=2020. Dexamethasone, pro-resolving lipid mediators and resolution of inflammation in COVID-19.|pdf=|usr=}}
{{tp|p=32965717|t=2020. SARS-CoV-2 infection in India bucks the trend: Trained innate immunity?|pdf=|usr=}}
{{tp|p=32978876|t=2020. Transmission-dynamics models for the SARS Coronavirus-2.|pdf=|usr=}}
{{tp|p=32838273|t=2020. Detection of severe acute respiratory syndrome coronavirus 2 in placentas with pathology and vertical transmission.|pdf=|usr=}}
{{tp|p=32996784|t=2020. Sex steroids skew ACE2 expression in human airway: a contributing factor to sex differences in COVID-19?|pdf=|usr=}}
{{tp|p=32851969|t=2020. Identification of Exertional Hypoxia and Its Implications in SARS-CoV-2 Pneumonia.|pdf=|usr=}}
{{tp|p=32925314|t=2020. Reduced Monocytic Human Leukocyte Antigen-DR Expression Indicates Immunosuppression in Critically Ill COVID-19 Patients.|pdf=|usr=}}
{{tp|p=32925313|t=2020. Human Leukocyte Antigen-DR Deficiency and Immunosuppression-Related End-Organ Failure in SARS-CoV2 Infection.|pdf=|usr=}}
{{tp|p=32968798|t=2020. Unveiling COVID-19-associated organ-specific cell types and cell-specific pathway cascade.|pdf=|usr=}}
{{tp|p=32914167|t=2020. Comparative host-pathogen protein-protein interaction analysis of recent coronavirus outbreaks and important host targets identification.|pdf=|usr=}}
{{tp|p=32966582|t=2020. SARS-CoV-2 infects and induces cytotoxic effects in human cardiomyocytes.|pdf=|usr=}}
{{tp|p=32966547|t=2020. Hypertension and SARS-CoV-2 infection: is inflammation the missing link?|pdf=|usr=}}
{{tp|p=32966765|t=2020. The Immunology of Multisystem Inflammatory Syndrome in Children with COVID-19.|pdf=|usr=}}
{{tp|p=32841599|t=2020. Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 Binding.|pdf=|usr=}}
{{tp|p=32946786|t=2020. Longitudinal Isolation of Potent Near-Germline SARS-CoV-2-Neutralizing Antibodies from COVID-19 Patients.|pdf=|usr=}}
{{tp|p=32810439|t=2020. Elevated Calprotectin and Abnormal Myeloid Cell Subsets Discriminate Severe from Mild COVID-19.|pdf=|usr=}}
{{tp|p=32810438|t=2020. Severe COVID-19 Is Marked by a Dysregulated Myeloid Cell Compartment.|pdf=|usr=}}
{{tp|p=32783916|t=2020. Structural Basis for Helicase-Polymerase Coupling in the SARS-CoV-2 Replication-Transcription Complex.|pdf=|usr=}}
{{tp|p=33010815|t=2020. Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity.|pdf=|usr=}}
{{tp|p=32991844|t=2020. Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology.|pdf=|usr=}}
{{tp|p=32991843|t=2020. Mapping Systemic Inflammation and Antibody Responses in Multisystem Inflammatory Syndrome in Children (MIS-C).|pdf=|usr=}}
{{tp|p=32970989|t=2020. SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and ACE2.|pdf=|usr=}}
{{tp|p=32991842|t=2020. Structural and Functional Analysis of the D614G SARS-CoV-2 Spike Protein Variant.|pdf=|usr=}}
{{tp|p=32979941|t=2020. Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19.|pdf=|usr=}}
{{tp|p=32979319|t=2020. Cancer, COVID-19, and Antiviral Immunity: The CAPTURE Study.|pdf=|usr=}}
{{tp|p=32976799|t=2020. COVID-19 Makes B Cells Forget, but T Cells Remember.|pdf=|usr=}}
{{tp|p=32877699|t=2020. Loss of Bcl-6-Expressing T Follicular Helper Cells and Germinal Centers in COVID-19.|pdf=|usr=}}
{{tp|p=33020722|t=2020. Broad host range of SARS-CoV-2 and the molecular basis for SARS-CoV-2 binding to cat ACE2.|pdf=|usr=}}
{{tp|p=32983570|t=2020. Temporal antibody responses to SARS-CoV-2 in patients of coronavirus disease 2019.|pdf=|usr=}}
{{tp|p=32953130|t=2020. SARS-CoV-2 N protein antagonizes type I interferon signaling by suppressing phosphorylation and nuclear translocation of STAT1 and STAT2.|pdf=|usr=}}
{{tp|p=32941787|t=2020. Human B Cell Clonal Expansion and Convergent Antibody Responses to SARS-CoV-2.|pdf=|usr=}}
{{tp|p=32841605|t=2020. Virus-Receptor Interactions of Glycosylated SARS-CoV-2 Spike and Human ACE2 Receptor.|pdf=|usr=}}
{{tp|p=32877692|t=2020. Elevated Glucose Levels Favor SARS-CoV-2 Infection and Monocyte Response through a HIF-1alpha/Glycolysis-Dependent Axis.|pdf=|usr=}}
{{tp|p=32810597|t=2020. Identification of Transcription Factors Regulating SARS-CoV-2 Entry Genes in the Intestine.|pdf=|usr=}}
{{tp|p=32917983|t=2020. Sepsis-associated severe interleukin-6 storm in critical coronavirus disease 2019.|pdf=|usr=}}
{{tp|p=32895485|t=2020. Linear epitopes of SARS-CoV-2 spike protein elicit neutralizing antibodies in COVID-19 patients.|pdf=|usr=}}
{{tp|p=32879471|t=2020. Expansion of atypical memory B cells is a prominent feature of COVID-19.|pdf=|usr=}}
{{tp|p=32963357|t=2020. Serum inflammatory factors are positively correlated with the production of specific antibodies in coronavirus disease 2019 patients.|pdf=|usr=}}
{{tp|p=32966801|t=2020. Activation of the SARS-CoV-2 Receptor Ace2 through JAK/STAT-Dependent Enhancers during Pregnancy.|pdf=|usr=}}
{{tp|p=32946807|t=2020. A Single-Cell RNA Expression Map of Human Coronavirus Entry Factors.|pdf=|usr=}}
{{tp|p=32941788|t=2020. SARS-CoV-2 ORF3b Is a Potent Interferon Antagonist Whose Activity Is Increased by a Naturally Occurring Elongation Variant.|pdf=|usr=}}
{{tp|p=32979938|t=2020. Evasion of Type I Interferon by SARS-CoV-2.|pdf=|usr=}}
{{tp|p=32904468|t=2020. Robust T Cell Response Toward Spike, Membrane, and Nucleocapsid SARS-CoV-2 Proteins Is Not Associated with Recovery in Critical COVID-19 Patients.|pdf=|usr=}}
{{tp|p=32839763|t=2020. SARS-CoV-2-Specific T Cells Exhibit Phenotypic Features of Helper Function, Lack of Terminal Differentiation, and High Proliferation Potential.|pdf=|usr=}}
{{tp|p=33015650|t=2020. Cross-Sectional Evaluation of Humoral Responses against SARS-CoV-2 Spike.|pdf=|usr=}}
{{tp|p=32835306|t=2020. Characterization and Treatment of SARS-CoV-2 in Nasal and Bronchial Human Airway Epithelia.|pdf=|usr=}}
{{tp|p=32838342|t=2020. Systems-Level Immunomonitoring from Acute to Recovery Phase of Severe COVID-19.|pdf=|usr=}}
{{tp|p=32861744|t=2020. The multifaceted role of plasminogen in inflammation.|pdf=|usr=}}
{{tp|p=32916095|t=2020. Estimating the Binding of Sars-CoV-2 Peptides to HLA Class I in Human Subpopulations Using Artificial Neural Networks.|pdf=|usr=}}
{{tp|p=32911691|t=2020. Dendritic Cells and SARS-CoV-2 Infection: Still an Unclarified Connection.|pdf=|usr=}}
{{tp|p=33003471|t=2020. Disharmonic Inflammatory Signatures in COVID-19: Augmented Neutrophils' but Impaired Monocytes' and Dendritic Cells' Responsiveness.|pdf=|usr=}}
{{tp|p=32859121|t=2020. SARS-CoV-2 Spike 1 Protein Controls Natural Killer Cell Activation via the HLA-E/NKG2A Pathway.|pdf=|usr=}}
{{tp|p=32854433|t=2020. Coronaviruses: Is Sialic Acid a Gate to the Eye of Cytokine Storm? From the Entry to the Effects.|pdf=|usr=}}
{{tp|p=32847031|t=2020. A New ERAP2/Iso3 Isoform Expression Is Triggered by Different Microbial Stimuli in Human Cells. Could It Play a Role in the Modulation of SARS-CoV-2 Infection?|pdf=|usr=}}
{{tp|p=32750325|t=2020. Chemical kinetics of the development of coronaviral infection in the human body: Critical conditions, toxicity mechanisms, "thermoheliox", and "thermovaccination".|pdf=|usr=}}
{{tp|p=32971122|t=2020. Deciphering the SSR incidences across viral members of Coronaviridae family.|pdf=|usr=}}
{{tp|p=32986926|t=2020. Binding of SARS-CoV-2 to cell receptors: a tale of molecular evolution.|pdf=|usr=}}
{{tp|p=32910974|t=2020. COVID-19 Acute Myocarditis and Multisystem Inflammatory Syndrome in Adult Intensive and Cardiac Care Units.|pdf=|usr=}}
{{tp|p=32931823|t=2020. Etoposide as Salvage Therapy for Cytokine Storm Due to COVID-19.|pdf=|usr=}}
{{tp|p=32221133|t=2020. Detection of serum immunoglobulin M and immunoglobulin G antibodies in 2019 novel coronavirus infected patients from different stages.|pdf=|usr=}}
{{tp|p=32938299|t=2020. Platelets Can Associate with SARS-Cov-2 RNA and Are Hyperactivated in COVID-19.|pdf=|usr=}}
{{tp|p=32897389|t=2020. Ultra-sensitive Serial Profiling of SARS-CoV-2 Antigens and Antibodies in Plasma to Understand Disease Progression in COVID-19 Patients with Severe Disease.|pdf=|usr=}}
{{tp|p=32901577|t=2020. Ribonucleocapsid assembly/packaging signals in the genomes of the coronaviruses SARS-CoV and SARS-CoV-2: detection, comparison and implications for therapeutic targeting.|pdf=|usr=}}
{{tp|p=33000143|t=2020. Dynamics of neutralizing antibody titers in the months after SARS-CoV-2 infection.|pdf=|usr=}}
{{tp|p=32941618|t=2020. A Granulocytic Signature Identifies COVID-19 and Its Severity.|pdf=|usr=}}
{{tp|p=32986250|t=2020. A bioinformatic prediction of antigen presentation from SARS-CoV-2 spike protein revealed a theoretical correlation of HLA-DRB101 with COVID-19 fatality in Mexican population: An ecological approach.|pdf=|usr=}}
{{tp|p=32975856|t=2020. Evolution of SARS-CoV-2 genome from December 2019 to late March 2020: Emerged haplotypes and informative Tag nucleotide variations.|pdf=|usr=}}
{{tp|p=32970329|t=2020. Genomic and proteomic mutation landscapes of SARS-CoV-2.|pdf=|usr=}}
{{tp|p=32966656|t=2020. Biochemical rationale for hypoalbuminemia in COVID-19 patients.|pdf=|usr=}}
{{tp|p=32966646|t=2020. Phylogenetic analysis of SARS-CoV-2 in the first few months since its emergence.|pdf=|usr=}}
{{tp|p=32966614|t=2020. Clinical value anti-SARS-COV-2 serum IgA titration in patients with COVID-19.|pdf=|usr=}}
{{tp|p=33006900|t=2020. Molecular Simulations and Network Modeling Reveal an Allosteric Signaling in the SARS-CoV-2 Spike Proteins.|pdf=|usr=}}
{{tp|p=32786692|t=2020. Studying the Effects of ACE2 Mutations on the Stability, Dynamics, and Dissociation Process of SARS-CoV-2 S1/hACE2 Complexes.|pdf=|usr=}}
{{tp|p=32786691|t=2020. Serum Proteomics in COVID-19 Patients: Altered Coagulation and Complement Status as a Function of IL-6 Level.|pdf=|usr=}}
{{tp|p=32937590|t=2020. Acetylated K676 TGFBIp as a severity diagnostic blood biomarker for SARS-CoV-2 pneumonia.|pdf=|usr=}}
{{tp|p=32963239|t=2020. Consensus transcriptional regulatory networks of coronavirus-infected human cells.|pdf=|usr=}}
{{tp|p=32985562|t=2020. Immune dysfunction following COVID-19, especially in severe patients.|pdf=|usr=}}
{{tp|p=32929138|t=2020. Analysis of the SARS-CoV-2 spike protein glycan shield reveals implications for immune recognition.|pdf=|usr=}}
{{tp|p=33020502|t=2020. SARS-CoV-2 spike protein predicted to form complexes with host receptor protein orthologues from a broad range of mammals.|pdf=|usr=}}
{{tp|p=32979900|t=2020. The assessment of the serum levels of TWEAK and prostaglandin F2? in COVID - 19.|pdf=|usr=}}
{{tp|p=32921745|t=2020. Novel Coronavirus (SARS-CoV-2) resistance in African populations: A cause worth exploring.|pdf=|usr=}}
{{tp|p=32921728|t=2020. The "perfect" storm: Current evidence on pediatric inflammatory multisystem disease during SARS-CoV-2 pandemic.|pdf=|usr=}}
{{tp|p=32921739|t=2020. Oncolytic effect of SARS-CoV2 in a patient with NK lymphoma.|pdf=|usr=}}
{{tp|p=32914749|t=2020. Revisiting Clinical Autopsies: Lessons to be Taken from the COVID-19 Pandemic.|pdf=|usr=}}
{{tp|p=32985209|t=2020. Genomic characterization and phylogenetic evolution of the SARS-CoV-2.|pdf=|usr=}}
{{tp|p=33010181|t=2020. Maximizing the value of human biospecimens: Lessons from coronavirus and the Seattle flu study.|pdf=|usr=}}
{{tp|p=32997945|t=2020. Biological Mechanisms of COVID-19 ARDS.|pdf=|usr=}}
{{tp|p=32997512|t=2020. Positive Bubble Study in Severe COVID-19 Indicates the Development of Anatomical Intra-pulmonary Shunts in Response to Microvascular Occlusion.|pdf=|usr=}}
{{tp|p=32997507|t=2020. Reply to: Positive Bubble Study in Severe COVID-19 Indicates the Development of Anatomical Intra-pulmonary Shunts in Response to Microvascular Occlusion.|pdf=|usr=}}
{{tp|p=32826529|t=2020. Comparison of RNA In Situ Hybridization and Immunohistochemistry Techniques for the Detection and Localization of SARS-CoV-2 in Human Tissues.|pdf=|usr=}}
{{tp|p=32996443|t=2020. Is Higher Viral Load in SARS-CoV-2 Associated with Death?|pdf=|usr=}}
{{tp|p=32897891|t=2020. Severe hyperphosphatasemia and severe acute respiratory syndrome coronavirus 2 infection in children.|pdf=|usr=}}
{{tp|p=33006605|t=2020. Systemic effects of missense mutations on SARS-CoV-2 spike glycoprotein stability and receptor-binding affinity.|pdf=|usr=}}
{{tp|p=32941261|t=2020. Myocarditis in Multisystem Inflammatory Syndrome in Children Associated With Coronavirus Disease 2019.|pdf=|usr=}}
{{tp|p=33020822|t=2020. Upper respiratory tract levels of SARS-CoV-2 RNA and duration of viral RNA shedding do not differ between patients with mild and severe/critical COVID-19.|pdf=|usr=}}
{{tp|p=32902889|t=2020. The emerging SARS-CoV-2 papain-like protease: Its relationship with recent coronavirus epidemics.|pdf=|usr=}}
{{tp|p=32897566|t=2020. Seroconversion against SARS-CoV-2 occurred after the recovery in patients with COVID-19.|pdf=|usr=}}
{{tp|p=32897544|t=2020. Immune response against SARS-CoV-2 in pediatric patients including young infants.|pdf=|usr=}}
{{tp|p=32910461|t=2020. The dynamics of immune response in COVID-19 patients with different illness severity.|pdf=|usr=}}
{{tp|p=32910458|t=2020. Apoptosis and immunophenotyping of peripheral blood lymphocytes in Iranian COVID-19 patients: Clinical and laboratory characteristics.|pdf=|usr=}}
{{tp|p=33009829|t=2020. The antibody response to the glycan alpha-Gal correlates with COVID-19 disease symptoms.|pdf=|usr=}}
{{tp|p=32940328|t=2020. Seroprevalence of anti-SARS-CoV-2 antibodies in residents of Karachi-challenges in acquiring herd immunity for COVID 19.|pdf=|usr=}}

{{tp|p=32894217|t=2020. Quantifying antibody kinetics and RNA detection during early-phase SARS-CoV-2 infection by time since symptom onset.|pdf=|usr=}}
{{tp|p=32930052|t=2020. SARS-CoV-2 neutralizing antibody responses are more robust in patients with severe disease.|pdf=|usr=}}
{{tp|p=33008679|t=2020. inverted question markInfeccion por SARS-CoV-2 como desencadenante de un sindrome inflamatorio sistemico?|pdf=|usr=}}
{{tp|p=32904601|t=2020. Mass Spectrometry Analysis of Newly Emerging Coronavirus HCoV-19 Spike Protein and Human ACE2 Reveals Camouflaging Glycans and Unique Post-Translational Modifications.|pdf=|usr=}}
{{tp|p=32959075|t=2020. Paediatric multisystem inflammatory syndrome associated with COVID-19: filling the gap between myocarditis and Kawasaki?|pdf=|usr=}}
{{tp|p=32949577|t=2020. Hypercytokinemia in COVID-19: Tear cytokine profile in hospitalized COVID-19 patients.|pdf=|usr=}}
{{tp|p=32974353|t=2020. SARS-CoV-2 Codon Usage Bias Downregulates Host Expressed Genes With Similar Codon Usage.|pdf=|usr=}}
{{tp|p=32850499|t=2020. Functional Pangenome Analysis Shows Key Features of E Protein Are Preserved in SARS and SARS-CoV-2.|pdf=|usr=}}
{{tp|p=33013929|t=2020. Variations in SARS-CoV-2 Spike Protein Cell Epitopes and Glycosylation Profiles During Global Transmission Course of COVID-19.|pdf=|usr=}}
{{tp|p=32983176|t=2020. What's Sex Got to Do With COVID-19? Gender-Based Differences in the Host Immune Response to Coronaviruses.|pdf=|usr=}}
{{tp|p=32983174|t=2020. Re-analysis of Single Cell Transcriptome Reveals That the NR3C1-CXCL8-Neutrophil Axis Determines the Severity of COVID-19.|pdf=|usr=}}
{{tp|p=32983172|t=2020. Cytokine Storm in COVID-19: "When You Come Out of the Storm, You Won't Be the Same Person Who Walked in".|pdf=|usr=}}
{{tp|p=32983157|t=2020. The Metabolic Changes and Immune Profiles in Patients With COVID-19.|pdf=|usr=}}
{{tp|p=32983152|t=2020. The Immune Response and Immunopathology of COVID-19.|pdf=|usr=}}
{{tp|p=32983141|t=2020. Obesity-Driven Deficiencies of Specialized Pro-resolving Mediators May Drive Adverse Outcomes During SARS-CoV-2 Infection.|pdf=|usr=}}
{{tp|p=32983106|t=2020. Analysis of Co-inhibitory Receptor Expression in COVID-19 Infection Compared to Acute Plasmodium falciparum Malaria: LAG-3 and TIM-3 Correlate With T Cell Activation and Course of Disease.|pdf=|usr=}}
{{tp|p=32973803|t=2020. Innate Immune Responses to Highly Pathogenic Coronaviruses and Other Significant Respiratory Viral Infections.|pdf=|usr=}}
{{tp|p=32922406|t=2020. The Comparative Immunological Characteristics of SARS-CoV, MERS-CoV, and SARS-CoV-2 Coronavirus Infections.|pdf=|usr=}}
{{tp|p=33013759|t=2020. Is There a Link Between the Pathogenic Human Coronavirus Envelope Protein and Immunopathology? A Review of the Literature.|pdf=|usr=}}
{{tp|p=32973730|t=2020. The Strengths of Scanning Electron Microscopy in Deciphering SARS-CoV-2 Infectious Cycle.|pdf=|usr=}}
{{tp|p=32974389|t=2020. SR/RS Motifs as Critical Determinants of Coronavirus Life Cycle.|pdf=|usr=}}
{{tp|p=33013423|t=2020. Age-Dependent Assessment of Genes Involved in Cellular Senescence, Telomere, and Mitochondrial Pathways in Human Lung Tissue of Smokers, COPD, and IPF: Associations With SARS-CoV-2 COVID-19 ACE2-TMPRSS2-Furin-DPP4 Axis.|pdf=|usr=}}
{{tp|p=32982760|t=2020. Mitochondria Targeted Viral Replication and Survival Strategies-Prospective on SARS-CoV-2.|pdf=|usr=}}
{{tp|p=32922297|t=2020. COVID-19 Usurps Host Regulatory Networks.|pdf=|usr=}}
{{tp|p=32943587|t=2020. Impact of Circulating SARS-CoV-2 Mutant G614 on the COVID-19 Pandemic.|pdf=|usr=}}
{{tp|p=32895641|t=2020. Integrative Network Biology Framework Elucidates Molecular Mechanisms of SARS-CoV-2 Pathogenesis.|pdf=|usr=}}
{{tp|p=33015593|t=2020. Mitochondria: In the Cross Fire of SARS-CoV-2 and Immunity.|pdf=|usr=}}
{{tp|p=33015591|t=2020. PPARgamma Cistrome Repression during Activation of Lung Monocyte-Macrophages in Severe COVID-19.|pdf=|usr=}}
{{tp|p=32989429|t=2020. SARS-CoV-2 Infection Boosts MX1 Antiviral Effector in COVID-19 Patients.|pdf=|usr=}}
{{tp|p=32939273|t=2020. Crystal structures of SARS-CoV-2 ADP-ribose phosphatase: from the apo form to ligand complexes.|pdf=|usr=}}
{{tp|p=32916324|t=2020. IFN-gamma receptor 2 deficiency initial mimicry of multisystem inflammatory syndrome in children (MIS-C).|pdf=|usr=}}
{{tp|p=32990278|t=2020. Antibody responses in COVID-19 patients.|pdf=|usr=}}
{{tp|p=32975374|t=2020. Naturally activated adaptive immunity in COVID-19 patients.|pdf=|usr=}}
{{tp|p=32949179|t=2020. STAT3 isoforms differentially affect ACE2 expression: A potential target for COVID-19 therapy.|pdf=|usr=}}
{{tp|p=32924263|t=2020. Identification of Hub genes associated with infection of three lung cell lines by SARS-CoV-2 with integrated bioinformatics analysis.|pdf=|usr=}}
{{tp|p=32966269|t=2020. Healthy donor T-cell responses to common cold coronaviruses and SARS-CoV-2.|pdf=|usr=}}
{{tp|p=33021506|t=2020. COVID-19 and myeloid cells: complex interplay correlates with lung severity.|pdf=|usr=}}
{{tp|p=32976117|t=2020. Are T cells helpful for COVID-19: the relationship between response and risk.|pdf=|usr=}}
{{tp|p=32957548|t=2020. Complex Immunometabolic Profiling Reveals the Activation of Cellular Immunity and Biliary Lesions in Patients with Severe COVID-19.|pdf=|usr=}}
{{tp|p=32989935|t=2020. COVID-19 Patients Upregulate Toll-like Receptor 4-mediated Inflammatory Signaling That Mimics Bacterial Sepsis.|pdf=|usr=}}
{{tp|p=32929291|t=2021. Structural dynamics of COVID-19 main protease.|pdf=|usr=}}
{{tp|p=32930936|t=2020. Infectivity of SARS-CoV-2: there Is Something More than D614G?|pdf=|usr=}}
{{tp|p=32885971|t=2020. The Answer Lies in the Energy: How Simple Atomistic Molecular Dynamics Simulations May Hold the Key to Epitope Prediction on the Fully Glycosylated SARS-CoV-2 Spike Protein.|pdf=|usr=}}
{{tp|p=32847856|t=2020. SARS-CoV-2 and Three Related Coronaviruses Utilize Multiple ACE2 Orthologs and Are Potently Blocked by an Improved ACE2-Ig.|pdf=|usr=}}
{{tp|p=33015645|t=2020. Clinical criteria for COVID-19-associated hyperinflammatory syndrome: a cohort study.|pdf=|usr=}}
{{tp|p=33015644|t=2020. Defining the scourge of COVID-19 hyperinflammatory syndrome.|pdf=|usr=}}
{{tp|p=32978313|t=2020. Rescue of SARS-CoV-2 from a Single Bacterial Artificial Chromosome.|pdf=|usr=}}
{{tp|p=32978311|t=2020. S Protein-Reactive IgG and Memory B Cell Production after Human SARS-CoV-2 Infection Includes Broad Reactivity to the S2 Subunit.|pdf=|usr=}}
{{tp|p=32948688|t=2020. Impaired Cytotoxic CD8(+) T Cell Response in Elderly COVID-19 Patients.|pdf=|usr=}}
{{tp|p=32913009|t=2020. Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.|pdf=|usr=}}
{{tp|p=32899009|t=2020. Analysis of type I IFN response and T cell activation in severe COVID-19/HIV-1 coinfection: A case report.|pdf=|usr=}}
{{tp|p=32997001|t=2020. Genomic and phylogenetic characterisation of an imported case of SARS-CoV-2 in Amazonas State, Brazil.|pdf=|usr=}}
{{tp|p=32916246|t=2020. Immune response in COVID-19: What do we currently know?|pdf=|usr=}}
{{tp|p=32911086|t=2020. Viral load of SARS-CoV-2 across patients and compared to other respiratory viruses.|pdf=|usr=}}
{{tp|p=32891874|t=2020. Improved binding of SARS-CoV-2 Envelope protein to tight junction-associated PALS1 could play a key role in COVID-19 pathogenesis.|pdf=|usr=}}
{{tp|p=32972948|t=2020. Whole-Genome Sequence of SARS-CoV-2 Isolate Siena-1/2020.|pdf=|usr=}}
{{tp|p=32972934|t=2020. Coding-Complete Genome Sequences of Three SARS-CoV-2 Strains from Bangladesh.|pdf=|usr=}}
{{tp|p=33019592|t=2020. Gut Microbiota Dysbiosis-Immune Hyperresponse-Inflammation Triad in Coronavirus Disease 2019 (COVID-19): Impact of Pharmacological and Nutraceutical Approaches.|pdf=|usr=}}
{{tp|p=32895815|t=2020. COVID-19-Spatfolge bei Kindern: Multisystemische Entzundung : Coronavirus-Pandemie.|pdf=|usr=}}
{{tp|p=32790663|t=2020. COVID-19-Associated Multisystem Inflammatory Syndrome in Children - United States, March-July 2020.|pdf=|usr=}}
{{tp|p=32888056|t=2020. GC usage of SARS-CoV-2 genes might adapt to the environment of human lung expressed genes.|pdf=|usr=}}
{{tp|p=32993497|t=2020. The role of host defences in Covid 19 and treatments thereof.|pdf=|usr=}}
{{tp|p=32945643|t=2020. SeXX and COVID-19: tussle between the two.|pdf=|usr=}}
{{tp|p=32938700|t=2020. Competitive SARS-CoV-2 Serology Reveals Most Antibodies Targeting the Spike Receptor-Binding Domain Compete for ACE2 Binding.|pdf=|usr=}}
{{tp|p=32871063|t=2020. Humoral Immune Response to SARS-CoV-2 in Iceland.|pdf=|usr=}}
{{tp|p=32948854|t=2020. Ultrasensitive high-resolution profiling of early seroconversion in patients with COVID-19.|pdf=|usr=}}
{{tp|p=32943637|t=2020. A systematic review of antibody mediated immunity to coronaviruses: kinetics, correlates of protection, and association with severity.|pdf=|usr=}}
{{tp|p=32943630|t=2020. SARS-CoV-2 seroprevalence and neutralizing activity in donor and patient blood.|pdf=|usr=}}
{{tp|p=32917884|t=2020. Molecular interaction and inhibition of SARS-CoV-2 binding to the ACE2 receptor.|pdf=|usr=}}
{{tp|p=32908300|t=2020. COVID-19 herd immunity: where are we?|pdf=|usr=}}
{{tp|p=33009506|t=2020. Fatty monocytes in COVID-19.|pdf=|usr=}}
{{tp|p=32895513|t=2020. Coordinated and sustained immune memory responses after mild COVID-19.|pdf=|usr=}}
{{tp|p=32895512|t=2020. SARS-CoV-2 ORF9c: a mysterious membrane-anchored protein that regulates immune evasion?|pdf=|usr=}}
{{tp|p=32895511|t=2020. Does a host restriction factor facilitate entry of SARS-CoV-2?|pdf=|usr=}}
{{tp|p=32995660|t=2020. Single cell sequencing unraveling genetic basis of shared immunologic switch between Severe COVID19 and Obesity.|pdf=|usr=}}
{{tp|p=32984641|t=2020. Gut microbiome dysbiosis and endotoxemia - Additional pathophysiological explanation for increased COVID-19 severity in obesity.|pdf=|usr=}}
{{tp|p=32939324|t=2020. Immune responses during COVID-19 infection.|pdf=|usr=}}
{{tp|p=32961074|t=2020. Cytokine storm and COVID-19: a chronicle of pro-inflammatory cytokines.|pdf=|usr=}}
{{tp|p=32898469|t=2020. SARS-CoV-2 envelope protein topology in eukaryotic membranes.|pdf=|usr=}}
{{tp|p=32999893|t=2020. Fever Patterns, Cytokine Profiles, and Outcomes in COVID-19.|pdf=|usr=}}
{{tp|p=32989419|t=2020. The Antibody Response to SARS-CoV-2 Infection.|pdf=|usr=}}
{{tp|p=32792288|t=2020. Hyperinflammation and the utility of immunomodulatory medications in children with COVID-19.|pdf=|usr=}}
{{tp|p=32891582|t=2020. Multi-system inflammatory syndrome in children & adolescents (MIS-C): A systematic review of clinical features and presentation.|pdf=|usr=}}
{{tp|p=32901164|t=2020. Apparent scaling of virus surface roughness-An example from the pandemic SARS-nCoV.|pdf=|usr=}}
{{tp|p=32911234|t=2020. A structured review of placental morphology and histopathological lesions associated with SARS-CoV-2 infection.|pdf=|usr=}}
{{tp|p=32997660|t=2020. IL6-mediated HCoV-host interactome regulatory network and GO/Pathway enrichment analysis.|pdf=|usr=}}
{{tp|p=32941419|t=2020. Genetic grouping of SARS-CoV-2 coronavirus sequences using informative subtype markers for pandemic spread visualization.|pdf=|usr=}}
{{tp|p=33006981|t=2020. Similarity between mutation spectra in hypermutated genomes of rubella virus and in SARS-CoV-2 genomes accumulated during the COVID-19 pandemic.|pdf=|usr=}}
{{tp|p=32976531|t=2020. The changes of the peripheral CD4+ lymphocytes and inflammatory cytokines in Patients with COVID-19.|pdf=|usr=}}
{{tp|p=32970753|t=2020. A web visualization tool using T cell subsets as the predictor to evaluate COVID-19 patient's severity.|pdf=|usr=}}
{{tp|p=32936826|t=2020. Isolation and characterization of severe acute respiratory syndrome coronavirus 2 in Turkey.|pdf=|usr=}}
{{tp|p=32903266|t=2020. Identification of immunodominant linear epitopes from SARS-CoV-2 patient plasma.|pdf=|usr=}}
{{tp|p=32913364|t=2020. A comprehensive, longitudinal analysis of humoral responses specific to four recombinant antigens of SARS-CoV-2 in severe and non-severe COVID-19 patients.|pdf=|usr=}}
{{tp|p=32894404|t=2020. The impact of aging and COVID-19 on our immune system: a high-resolution map from single cell analysis.|pdf=|usr=}}
{{tp|p=32965372|t=2020. Kawasaki and COVID-19 disease in children: a systematic review.|pdf=|usr=}}
{{tp|p=32936318|t=2020. Kawasaki-like disease in children with COVID-19.|pdf=|usr=}}
{{tp|p=32895366|t=2020. Storm of soluble immune checkpoints associated with disease severity of COVID-19.|pdf=|usr=}}
{{tp|p=32929061|t=2020. Type I IFN deficiency: an immunological characteristic of severe COVID-19 patients.|pdf=|usr=}}
{{tp|p=33024093|t=2020. SARS-CoV-2-specific T-cells in unexposed humans: presence of cross-reactive memory cells does not equal protective immunity.|pdf=|usr=}}
{{tp|p=33024073|t=2020. Main protease of SARS-CoV-2 serves as a bifunctional molecule in restricting type I interferon antiviral signaling.|pdf=|usr=}}
{{tp|p=32984664|t=2020. Identification of Geographic Specific SARS-Cov-2 Mutations by Random Forest Classification and Variable Selection Methods.|pdf=|usr=}}
{{tp|p=32920296|t=2020. Identification of the antithrombotic protein S as a potential target of the SARS-CoV-2 papain-like protease.|pdf=|usr=}}
{{tp|p=32815359|t=2020. Rettelse: Multiorgan inflammatorisk syndrom assosiert med sars-CoV-2 hos et barn.|pdf=|usr=}}
{{tp|p=32904637|t=2020. The role of carbon monoxide and heme oxygenase-1 in COVID-19.|pdf=|usr=}}
{{tp|p=32954666|t=2020. Comprehensive annotations of the mutational spectra of SARS-CoV-2 spike protein: a fast and accurate pipeline.|pdf=|usr=}}
{{tp|p=32953471|t=2020. Proprotein convertase furin in SARS-CoV-2 and non-small cell lung cancer.|pdf=|usr=}}
{{tp|p=32923679|t=2020. C-C chemokine receptor type 5 links COVID-19, rheumatoid arthritis, and Hydroxychloroquine: in silico analysis.|pdf=|usr=}}
{{tp|p=33024515|t=2020. Immunological aspects of COVID-19: What do we know?|pdf=|usr=}}
{{tp|p=32917722|t=2020. Sphingosine prevents binding of SARS-CoV-2 spike to its cellular receptor ACE2.|pdf=|usr=}}
{{tp|p=32922564|t=2020. Coronavirus: a shift in focus away from IFN response and towards other inflammatory targets.|pdf=|usr=}}
{{tp|p=32796063|t=2020. Neuronal Ablation of Alpha/Beta Interferon (IFN-alpha/beta) Signaling Exacerbates Central Nervous System Viral Dissemination and Impairs IFN-gamma Responsiveness in Microglia/Macrophages.|pdf=|usr=}}
{{tp|p=32938761|t=2020. Type I Interferon Susceptibility Distinguishes SARS-CoV-2 from SARS-CoV.|pdf=|usr=}}

{{tp|p=32934770|t=2020. Structural Impact of Mutation D614G in SARS-CoV-2 Spike Protein: Enhanced Infectivity and Therapeutic Opportunity.|pdf=|usr=}}
{{tp|p=32952147|t=2020. Atypical Chest Computed Tomography Finding of Predominant Interstitial Thickening in a Patient with Coronavirus Disease 2019 (COVID-19) Pneumonia.|pdf=|usr=}}
{{tp|p=32919977|t=2020. Immunopathology of Hyperinflammation in COVID-19.|pdf=|usr=}}
{{tp|p=32876012|t=2020. Case Report: Adrenal Pathology Findings in Severe COVID-19: An Autopsy Study.|pdf=|usr=}}
{{tp|p=32950319|t=2020. Bell's palsy in a pediatric patient with hyper IgM syndrome and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).|pdf=|usr=}}
{{tp|p=32992681|t=2020. Identification of Novel Hypothalamic MicroRNAs as Promising Therapeutics for SARS-CoV-2 by Regulating ACE2 and TMPRSS2 Expression: An In Silico Analysis.|pdf=|usr=}}
{{tp|p=32954242|t=2020. Host tolerance contributes to persistent viral shedding in COVID-19.|pdf=|usr=}}
{{tp|p=32923992|t=2020. Multisystem inflammatory syndrome in children: A systematic review.|pdf=|usr=}}
{{tp|p=32984786|t=2020. The spectrum of biochemical alterations associated with organ dysfunction and inflammatory status and their association with disease outcomes in severe COVID-19: A longitudinal cohort and time-series design study.|pdf=|usr=}}
{{tp|p=33001029|t=2020. Dynamically evolving novel overlapping gene as a factor in the SARS-CoV-2 pandemic.|pdf=|usr=}}
{{tp|p=32983015|t=2020. Picking up a Fight: Fine Tuning Mitochondrial Innate Immune Defenses Against RNA Viruses.|pdf=|usr=}}
{{tp|p=32984206|t=2020. Pediatric Inflammatory Multisystem Syndrome: Statement by the Pediatric Section of the European Society for Emergency Medicine and European Academy of Pediatrics.|pdf=|usr=}}
{{tp|p=32974046|t=2020. Toll-like receptors and COVID-19: a two-faced story with an exciting ending.|pdf=|usr=}}
{{tp|p=33005212|t=2020. In silico identification of conserved cis-acting RNA elements in the SARS-CoV-2 genome.|pdf=|usr=}}
{{tp|p=33015411|t=2020. Identification of twenty-five mutations in surface glycoprotein (Spike) of SARS-CoV-2 among Indian isolates and their impact on protein dynamics.|pdf=|usr=}}
{{tp|p=32954047|t=2020. Genetic characterization of structural and open reading Fram-8 proteins of SARS-CoV-2 isolates from different countries.|pdf=|usr=}}
{{tp|p=33007398|t=2020. Genetics and genomics of SARS-CoV-2: A review of the literature with the special focus on genetic diversity and SARS-CoV-2 genome detection.|pdf=|usr=}}
{{tp|p=32966857|t=2020. Mutations on COVID-19 diagnostic targets.|pdf=|usr=}}
{{tp|p=32927009|t=2020. Molecular phylogeny and missense mutations of envelope proteins across coronaviruses.|pdf=|usr=}}
{{tp|p=32920121|t=2020. SARS-CoV-2 transcriptome analysis and molecular cataloguing of immunodominant epitopes for multi-epitope based vaccine design.|pdf=|usr=}}
{{tp|p=33017875|t=2020. Confidence intervals for the COVID-19 neutralizing antibody retention rate in the Korean population.|pdf=|usr=}}
{{tp|p=33017874|t=2020. Computational analysis of SARS-CoV-2, SARS-CoV, and MERS-CoV genome using MEGA.|pdf=|usr=}}
{{tp|p=32902818|t=2020. A geroscience perspective on immune resilience and infectious diseases: a potential case for metformin.|pdf=|usr=}}
{{tp|p=32983837|t=2020. Evaluation of the SARS-CoV-2-IgG response in outpatients by five commercial immunoassays.|pdf=|usr=}}
{{tp|p=32984566|t=2020. Selective pressure on SARS-CoV-2 protein coding genes and glycosylation site prediction.|pdf=|usr=}}
{{tp|p=32904785|t=2020. Integrate structural analysis, isoform diversity, and interferon-inductive propensity of ACE2 to predict SARS-CoV2 susceptibility in vertebrates.|pdf=|usr=}}
{{tp|p=32984567|t=2020. A SARS-CoV-2 host infection model network based on genomic human Transcription Factors (TFs) depletion.|pdf=|usr=}}
{{tp|p=32904861|t=2020. Antibody response to SARS-Co-V-2, diagnostic and therapeutic implications.|pdf=|usr=}}
{{tp|p=32950268|t=2020. Characteristics of immune cells and cytokines in patients with coronavirus disease 2019 in Guangzhou, China.|pdf=|usr=}}
{{tp|p=32953455|t=2020. A challenging case of multisystem inflammatory syndrome in children related to coronavirus Disease-19 hospitalized under adult medical service.|pdf=|usr=}}
{{tp|p=33007369|t=2020. "Cytokine storm", not only in COVID-19 patients. Mini-review.|pdf=|usr=}}
{{tp|p=33007368|t=2020. How NETosis could drive "Post-COVID-19 syndrome" among survivors.|pdf=|usr=}}
{{tp|p=32989677|t=2020. Immune characteristics distinguish patients with severe disease associated with SARS-CoV-2.|pdf=|usr=}}
{{tp|p=32930973|t=2020. Multisystem Inflammatory Syndrome in Children Associated with COVID 19 Treated with Oral Steroid.|pdf=|usr=}}
{{tp|p=32950697|t=2020. Substitutions in Spike and Nucleocapsid proteins of SARS-CoV-2 circulating in South America.|pdf=|usr=}}
{{tp|p=33014208|t=2020. How COVID-19 induces cytokine storm with high mortality.|pdf=|usr=}}
{{tp|p=33002623|t=2020. Patients with Covid-19 exhibit different immunological profiles according to their clinical presentation.|pdf=|usr=}}
{{tp|p=32920233|t=2020. Antibody-dependent enhancement of coronavirus.|pdf=|usr=}}
{{tp|p=32920235|t=2020. Covid-19 hyperinflammation and post-Covid-19 illness may be rooted in mast cell activation syndrome.|pdf=|usr=}}
{{tp|p=32945352|t=2020. Transcriptomic analysis of COVID19 lungs and bronchoalveolar lavage fluid samples reveals predominant B cell activation responses to infection.|pdf=|usr=}}
{{tp|p=32993015|t=2020. Role of SARS-CoV-2 in Altering the RNA-Binding Protein and miRNA-Directed Post-Transcriptional Regulatory Networks in Humans.|pdf=|usr=}}
{{tp|p=32933166|t=2020. Host Synthesized Carbohydrate Antigens on Viral Glycoproteins as "Achilles' Heel" of Viruses Contributing to Anti-Viral Immune Protection.|pdf=|usr=}}
{{tp|p=32917729|t=2020. Serological Assays Estimate Highly Variable SARS-CoV-2 Neutralizing Antibody Activity in Recovered COVID19 Patients.|pdf=|usr=}}
{{tp|p=32997749|t=2020. Paediatric Inflammatory Multisystem Syndrome temporally associated with SARS-CoV-2 (PIMS-TS) in a patient receiving Infliximab therapy for Inflammatory Bowel Disease.|pdf=|usr=}}
{{tp|p=33011038|t=2020. Multisystem Inflammatory Syndrome in Children (MIS-C) in an Adolescent that Developed Coronary Aneurysms: A Case Report and Review of the Literature.|pdf=|usr=}}
{{tp|p=32954708|t=2020. Analysis of Host Cell Receptor GRP78 for Potential Natural Reservoirs of SARS-CoV-2.|pdf=|usr=}}
{{tp|p=32970885|t=2020. Comment on 'Drug reaction with eosinophilia and systemic symptoms syndrome in a patient with COVID-19': involvement of herpesvirus reactivations and adverse drug reactions in diverse cutaneous manifestations and overall disease severity of COVID-19.|pdf=|usr=}}
{{tp|p=32956726|t=2020. Kinetics of SARS-CoV-2 specific antibodies (IgM, IgA, IgG) in non-hospitalized patients four months following infection.|pdf=|usr=}}
{{tp|p=32920062|t=2020. A possible role for GRP78 in cross vaccination against COVID-19.|pdf=|usr=}}
{{tp|p=32853600|t=2020. Diagnostic significance of SARS-CoV-2 IgM positive/IgG negative antibody profile in symptomatic patients with suspected COVID-19 testing negative by RT-PCR.|pdf=|usr=}}
{{tp|p=32853599|t=2020. COVID-19 patients display distinct SARS-CoV-2 specific T-cell responses according to disease severity.|pdf=|usr=}}
{{tp|p=32853597|t=2020. SARS-CoV-2 IgG and IgA antibody response is gender dependent; and IgG antibodies rapidly decline early on.|pdf=|usr=}}
{{tp|p=32910175|t=2020. SARS-CoV-2 Antibody Avidity Responses in COVID-19 Patients and Convalescent Plasma Donors.|pdf=|usr=}}
{{tp|p=32919931|t=2020. Syndrome resembling Kawasaki disease in COVID-19 asymptomatic children.|pdf=|usr=}}
{{tp|p=32982366|t=2020. Role of IFN and Complements System: Innate Immunity in SARS-CoV-2.|pdf=|usr=}}
{{tp|p=32991738|t=2020. Overexpression of the SARS-CoV-2 receptor ACE2 is induced by cigarette smoke in bronchial and alveolar epithelia.|pdf=|usr=}}
{{tp|p=32979386|t=2020. Use of tocilizumab in multisystem inflammatory syndrome in children associated with severe acute respiratory syndrome coronavirus 2.|pdf=|usr=}}
{{tp|p=32946801|t=2020. Multisystem inflammatory syndrome associated with COVID-19 from the pediatric emergency physician's point of view.|pdf=|usr=}}
{{tp|p=32945863|t=2020. Pediatric Inflammatory Multisystem Syndrome: Time to Collaborate.|pdf=|usr=}}
{{tp|p=32951037|t=2020. Defibrotide for the Treatment of Pediatric Inflammatory Multisystem Syndrome Temporally Associated With Severe Acute Respiratory Syndrome Coronavirus 2 Infection in 2 Pediatric Patients.|pdf=|usr=}}
{{tp|p=32919067|t=2020. A graph-based approach identifies dynamic H-bond communication networks in spike protein S of SARS-CoV-2.|pdf=|usr=}}
{{tp|p=32967693|t=2020. A persistently replicating SARS-CoV-2 variant derived from an asymptomatic individual.|pdf=|usr=}}
{{tp|p=32938769|t=2020. The Enzymatic Activity of the nsp14 Exoribonuclease Is Critical for Replication of MERS-CoV and SARS-CoV-2.|pdf=|usr=}}
{{tp|p=32937615|t=2020. High levels of SARS-CoV-2-specific T cells with restricted functionality in severe courses of COVID-19.|pdf=|usr=}}
{{tp|p=32972123|t=2020. Dynamics of viral load and anti-SARS-CoV-2 antibodies in patients with positive RT-PCR results after recovery from COVID-19.|pdf=|usr=}}
{{tp|p=32956615|t=2020. A national consensus management pathway for paediatric inflammatory multisystem syndrome temporally associated with COVID-19 (PIMS-TS): results of a national Delphi process.|pdf=|usr=}}
{{tp|p=32835654|t=2020. Multisystem inflammatory syndrome in children in South Africa.|pdf=|usr=}}
{{tp|p=32979317|t=2020. The complexities of SARS-CoV-2 serology.|pdf=|usr=}}
{{tp|p=32987502|t=2020. The within-host viral kinetics of SARS-CoV-2.|pdf=|usr=}}
{{tp|p=32944295|t=2020. Impact of glycan cloud on the B-cell epitope prediction of SARS-CoV-2 Spike protein.|pdf=|usr=}}
{{tp|p=2972994|t=1988. Sequence specificity of streptozotocin-induced mutations.|pdf=|usr=}}
{{tp|p=32958678|t=2020. Low genetic diversity may be an Achilles heel of SARS-CoV-2.|pdf=|usr=}}
{{tp|p=32956843|t=2021. Angiotensin-converting enzyme 2 (ACE2): COVID 19 gate way to multiple organ failure syndromes.|pdf=|usr=}}
{{tp|p=32965173|t=2020. Secondary structure of the SARS-CoV-2 5'-UTR.|pdf=|usr=}}
{{tp|p=32991014|t=2020. The cytokine storm-An appropriate, over-reactive response to SARS-CoV-2 or the wrong immune pathway?|pdf=|usr=}}
{{tp|p=33024223|t=2020. Sofosbuvir terminated RNA is more resistant to SARS-CoV-2 proofreader than RNA terminated by Remdesivir.|pdf=|usr=}}
{{tp|p=33024213|t=2020. SARS-CoV-2 S1 and N-based serological assays reveal rapid seroconversion and induction of specific antibody response in COVID-19 patients.|pdf=|usr=}}
{{tp|p=32963115|t=2020. Upper respiratory viral load in asymptomatic individuals and mildly symptomatic patients with SARS-CoV-2 infection.|pdf=|usr=}}
{{tp|p=32972818|t=2020. COVID-19 and Metabolic Syndrome: NF-kappaB Activation. Crossroads.|pdf=|usr=}}
{{tp|p=32921279|t=2020. Highly conserved binding region of ACE2 as a receptor for SARS-CoV-2 between humans and mammals.|pdf=|usr=}}
{{tp|p=32921711|t=2020. An Outbreak of Kawasaki-like Disease in children during SARS-CoV- 2 Epidemic: No Surprise?|pdf=|usr=}}
{{tp|p=32969849|t=2020. Atypical Endovascular Cells in SARS-CoV-2 Pneumonia.|pdf=|usr=}}
{{tp|p=32915505|t=2020. Structural Characterization of N-Linked Glycans in the Receptor Binding Domain of the SARS-CoV-2 Spike Protein and their Interactions with Human Lectins.|pdf=|usr=}}
{{tp|p=32907802|t=2020. Response to: 'Correspondence on 'Lung involvement in macrophage activation syndrome and severe COVID-19: results from a cross-sectional study to assess clinical, laboratory and artificial intelligence-radiological differences' by Ruscitti et al' by Chen et al.|pdf=|usr=}}
{{tp|p=32907800|t=2020. Correspondence on 'Lung involvement in macrophage activation syndrome and severe COVID-19: results from a cross-sectional study to assess clinical, laboratory and artificial intelligence-radiological differences' by Ruscitti et al.|pdf=|usr=}}
{{tp|p=32978236|t=2020. Correspondence on 'Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID-19): a multicentre cohort' by Pouletty et al.|pdf=|usr=}}
{{tp|p=32958511|t=2020. Correspondence on 'Interleukin-6 receptor blockade with subcutaneous tocilizumab in severe COVID-19 pneumonia and hyperinflammation: case-control study'.|pdf=|usr=}}
{{tp|p=32958508|t=2020. Correspondence to 'Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID-19): a multicentre cohort'.|pdf=|usr=}}
{{tp|p=32933921|t=2020. Paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS): what does the future hold?|pdf=|usr=}}
{{tp|p=32943427|t=2020. Covid-19: Do many people have pre-existing immunity?|pdf=|usr=}}
{{tp|p=32920919|t=2020. Are SARS-CoV-2 IgA antibodies in paediatric patients with chilblain-like lesions indicative of COVID-19 asymptomatic or paucisymptomatic infection?|pdf=|usr=}}
{{tp|p=32902374|t=2020. Analysis of partial sequences of the RNA-dependent RNA polymerase gene as a tool for genus and subgenus classification of coronaviruses.|pdf=|usr=}}
{{tp|p=32902372|t=2020. Predicting the recombination potential of severe acute respiratory syndrome coronavirus 2 and Middle East respiratory syndrome coronavirus.|pdf=|usr=}}
{{tp|p=32985922|t=2020. Early Identification of IgA Anti-SARSCoV-2 in Milk of Mother With COVID-19 Infection.|pdf=|usr=}}
{{tp|p=32826281|t=2020. Neonatal and Children's Immune System and COVID-19: Biased Immune Tolerance versus Resistance Strategy.|pdf=|usr=}}
{{tp|p=32978281|t=2020. Discordance between Serum Neutralizing Antibody Titers and the Recovery from COVID-19.|pdf=|usr=}}
{{tp|p=32958687|t=2020. Immune Response Resetting as a Novel Strategy to Overcome SARS-CoV-2-Induced Cytokine Storm.|pdf=|usr=}}
{{tp|p=32930458|t=2020. Regulatory CD4(+) and CD8(+) T cells are negatively correlated with CD4(+) /CD8(+) T cell ratios in patients acutely infected with SARS-CoV-2.|pdf=|usr=}}
{{tp|p=32930456|t=2020. Cytokine release syndrome in COVID-19: Innate immune, vascular, and platelet pathogenic factors differ in severity of disease and sex.|pdf=|usr=}}
{{tp|p=32918747|t=2020. Ultrastructure of cell trafficking pathways and coronavirus: how to recognise the wolf amongst the sheep.|pdf=|usr=}}
{{tp|p=32969960|t=2020. Features of Intestinal Disease Associated with COVID-Related Multisystem Inflammatory Syndrome in Children.|pdf=|usr=}}
{{tp|p=32924059|t=2020. The Natural History of SARS-Cov-2 Related Multisystem Inflammatory Syndrome in Children (MIS-C): A Systematic Review.|pdf=|usr=}}
{{tp|p=31743644|t=2019. Membrane Cholesterol Modulates Oligomeric Status and Peptide-Membrane Interaction of Severe Acute Respiratory Syndrome Coronavirus Fusion Peptide.|pdf=|usr=}}
{{tp|p=32989174|t=2020. MAIT cell activation and dynamics associated with COVID-19 disease severity.|pdf=|usr=}}
{{tp|p=32943497|t=2020. Longitudinal immune profiling reveals key myeloid signatures associated with COVID-19.|pdf=|usr=}}
{{tp|p=32994211|t=2020. High-resolution structures of the SARS-CoV-2 2'-O-methyltransferase reveal strategies for structure-based inhibitor design.|pdf=|usr=}}
{{tp|p=32958614|t=2020. Immune responses to SARS-CoV-2 infection in hospitalized pediatric and adult patients.|pdf=|usr=}}
{{tp|p=32994364|t=2020. Viral epitope profiling of COVID-19 patients reveals cross-reactivity and correlates of severity.|pdf=|usr=}}
{{tp|p=32958581|t=2020. Immune life history, vaccination, and the dynamics of SARS-CoV-2 over the next 5 years.|pdf=|usr=}}
{{tp|p=32972996|t=2020. Autoantibodies against type I IFNs in patients with life-threatening COVID-19.|pdf=|usr=}}
{{tp|p=32972995|t=2020. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19.|pdf=|usr=}}
{{tp|p=32958580|t=2020. Free fatty acid binding pocket in the locked structure of SARS-CoV-2 spike protein.|pdf=|usr=}}

{{tp|p=32881367|t=2020. Global Initiative Seeks to Crack the COVID-19 Genetic Code.|pdf=|usr=}}
{{tp|p=32912866|t=2020. Paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS): the Evelina Experience.|pdf=|usr=}}
{{tp|p=32933913|t=2020. Paediatric case of prolonged COVID-19 manifesting as PMIS-TS and atypical Kawasaki.|pdf=|usr=}}
{{tp|p=32943758|t=2020. Clinical characterization and risk factors associated with cytokine release syndrome induced by COVID-19 and chimeric antigen receptor T-cell therapy.|pdf=|usr=}}
{{tp|p=32966752|t=2020. Cardiometabolic Traits, Sepsis, and Severe COVID-19: A Mendelian Randomization Investigation.|pdf=|usr=}}
{{tp|p=32935083|t=2020. Management of Multisystem Inflammatory Syndrome in Children Associated with COVID-19: A Survey from the International Kawasaki Disease Registry.|pdf=|usr=}}
{{tp|p=32967859|t=2020. The pulmonary pathology of COVID-19.|pdf=|usr=}}
{{tp|p=32948868|t=2020. SARS-CoV-2 spreads to lymph nodes and strongly expands CD4+ TEMRA cells in a patient with mild COVID-19.|pdf=|usr=}}
{{tp|p=32927483|t=2020. Kinetics of SARS-CoV-2 Antibody Avidity Maturation and Association with Disease Severity.|pdf=|usr=}}
{{tp|p=32907819|t=2020. Pediatric inflammatory multisystem syndrome temporally associated with COVID-19: a spectrum of diseases with many names.|pdf=|usr=}}
{{tp|p=33020707|t=2020. Structural insight into the recognition of S-adenosyl-L-homocysteine and sinefungin in SARS-CoV-2 Nsp16/Nsp10 RNA cap 2'-O-Methyltransferase.|pdf=|usr=}}
{{tp|p=32977223|t=2020. Immunological features of coronavirus disease 2019 in patients with cancer.|pdf=|usr=}}
{{tp|p=33022277|t=2020. ACE2-containing extracellular vesicles and exomeres bind the SARS-CoV-2 spike protein.|pdf=|usr=}}
{{tp|p=33025514|t=2020. Low-Dose Dexamethasone Following IVIG in Pediatric Inflammatory Multisystem Syndrome in Temporal Association with COVID-19 (PIMS-TC).|pdf=|usr=}}
{{tp|p=32986832|t=2020. Biased mutation and selection in RNA viruses.|pdf=|usr=}}
{{tp|p=32941612|t=2020. Potential pathogenicity determinants identified from structural proteomics of SARS-CoV and SARS-CoV-2.|pdf=|usr=}}
{{tp|p=33000221|t=2020. Neuropilin1 as a new potential SARSCoV2 infection mediator implicated in the neurologic features and central nervous system involvement of COVID19.|pdf=|usr=}}
{{tp|p=32995557|t=2020. Integrated genomic view of SARS-CoV-2 in India.|pdf=|usr=}}
{{tp|p=32976188|t=2020. High level of defensin alpha 5 in intestine may explain the low incidence of diarrhoea in COVID-19 patients.|pdf=|usr=}}
{{tp|p=32910469|t=2020. Expansion of plasmablasts and loss of memory B cells in peripheral blood from COVID-19 patients with pneumonia.|pdf=|usr=}}
{{tp|p=32935333|t=2020. T-cell responses and therapies against SARS-CoV-2 infection.|pdf=|usr=}}
{{tp|p=33001920|t=2020. Light and corona: guided-wave readout for coronavirus spike protein-host-receptor binding.|pdf=|usr=}}
{{tp|p=33009246|t=2020. SARS-CoV-2 Spike protein co-opts VEGF-A/Neuropilin-1 receptor signaling to induce analgesia.|pdf=|usr=}}
{{tp|p=32979740|t=2020. Diffuse alveolar damage and thrombotic microangiopathy are the main histopathological findings in lung tissue biopsy samples of COVID-19 patients.|pdf=|usr=}}
{{tp|p=32897642|t=2020. The potential threat of multisystem inflammatory syndrome in children during the COVID-19 pandemic.|pdf=|usr=}}
{{tp|p=33003176|t=2020. Multisystem Inflammatory Syndrome in Children Associated With Coronavirus Disease 2019 in a Children's Hospital in New York City: Patient Characteristics and an Institutional Protocol for Evaluation, Management, and Follow-Up.|pdf=|usr=}}
{{tp|p=32970023|t=2020. Distinguishing Multisystem Inflammatory Syndrome in Children From Kawasaki Disease and Benign Inflammatory Illnesses in the SARS-CoV-2 Pandemic.|pdf=|usr=}}
{{tp|p=32925543|t=2020. Acute Appendicitis in Multisystem Inflammatory Syndrome in Children With COVID-19.|pdf=|usr=}}
{{tp|p=32947601|t=2020. Multisystem Inflammatory Syndrome (MIS-C) Surveillance and COVID-19 in Latin America.|pdf=|usr=}}
{{tp|p=32925547|t=2020. A Systematic Review of Multisystem Inflammatory Syndrome in Children Associated With SARS-CoV-2 Infection.|pdf=|usr=}}
{{tp|p=32898090|t=2020. MIS-C After ARDS Associated With SARS-CoV-2.|pdf=|usr=}}
{{tp|p=32907921|t=2020. SARS-CoV-2 Polymorphisms and Multisystem Inflammatory Syndrome in Children.|pdf=|usr=}}
{{tp|p=32973121|t=2020. Multisystem Inflammatory Syndrome in Children and SARS-CoV-2 Serology.|pdf=|usr=}}